Gleevec 400 mg/1
imatinib mesylate · TABLET · Novartis Pharmaceuticals Corporation
Gleevec is a tablet containing imatinib mesylate at 400 mg/1, taken oral. Manufactured by Novartis Pharmaceuticals Corporation.
Key Facts
- Brand Name
- Gleevec
- Generic Name
- imatinib mesylate
- NDC Code (Product)
0078-0649- Manufacturer
- Novartis Pharmaceuticals Corporation
- Strength
- 400 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA021588
- Marketing Start
- 12/23/2014
Recall History
Kroger Specialty Pharmacy, Inc.
Lack of Processing Controls.
Frequently Asked Questions
What is Gleevec used for?
Gleevec contains imatinib mesylate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Gleevec a controlled substance?
Gleevec is not classified as a controlled substance by the DEA.
What is the generic name for Gleevec?
The generic name for Gleevec is imatinib mesylate. There are 10 other brand versions of imatinib mesylate.
What is the NDC code for Gleevec 400 mg/1?
The NDC (National Drug Code) for Gleevec 400 mg/1 is 0078-0649, listed by Novartis Pharmaceuticals Corporation.
Other Gleevec Dosages
Other Imatinib Brands
See all →- Imatinib mesylate 400 mg400 mg/172485-203
- Imatinib Mesylate400 mg/168001-623
- imatinib mesylate400 mg/168001-491
- Imatinib Mesylate400 mg/160505-2901
- imatinib mesylate100 mg/167184-0532
- Imatinib mesylate400 mg/167877-634
- Imatinib Mesylate100 mg/168001-622
- Imatinib Mesylate400 mg/182009-087
- imatinib mesylate400 mg/10832-0533
- Imatinib Mesylate100 mg/10093-7629
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)